Antonio Georgiev; Julija Zhivadinovik

doi:10.24125/sanamed.v11i3.166

Correction: COCAINE CARDIOMYOPATHY A CASE REPORT (2014, Vol 9, issue 3, p. 233237.)

Antonio Georgiev, Julija Zhivadinovik

Abstract

In Sanamed Medical Journal, vol. 9, issue 3, in the text titled COCAINE CARDIOMYOPATHY A CASE REPORT authors made a mistake by inadequately citing parts of scientific paper, in sections Introduction and Discussion. The mistake was discovered by Center for Evaluation in Education and Science (CEON). Authors were informed from the Editorial Board of Medical Journal Sanamed and the stated parts of paper were timely corrected.

Abstract: The second most commonly used drug in the world is cocaine. Its use is the most common cause of death among drug users. The use of cocaine is associated with acute and chronic complications. Mostly affected system in the human bodys cardiovascular system. Cocaine cardiomyopathy may result from the use of cocaine.

This article presents a first case in Republic of Macedonia of 24-year-old male with reversible cocaine-related cardiomyopathy. Clinical presentation, laboratory, X-ray, ultrasound findings and treatment are reviewed.

Key words: cocaine, reversible cocaine cardiomyopathy, diagnosis, treatment

Keywords

cocaine; reversible cocaine cardiomyopathy; diagnosis; treatment

Full Text:

PDF

References

Finkel JB, Marhefka GD. Rethinking cocaine-associated chest pain and acute coronary syndromes. Mayo Clin Proc. 2011; 86(12): 1198–207.

Egred M, Davis GK. Cocaine and the heart. Postgrad Med J. 2005; 81(959): 568–71.

SAMHSA - Substance abuse and mental health service administration. Sharp decline also continues for methamphetamine use. US Department of Health and Human Services (DHS); Office of Applied Studies Results from the 2008 National Survey on Drug Use and Health: National Findings. http://oas.samhsa.gov/nsduh/2k8nsduh/2k8Results.cfm. 2009.

Schwartz BG, Rezkalla S, Kloner RA. Cardiovascular effects of cocaine. Circulation. 2010; 122(24): 2558–69.

Howell LL, Kimmel HL. Monoamine transporters and psychostimulant addiction. Biochem Pharmacol. 2008; 75(1): 196–217.

Phillips K, Luk A, Soor GS, Abraham JR, Leong S, Butany J. Cocaine cardiotoxicity: a review of the pathophysiology, pathology, and treatment options. Am J Cardiovasc Drugs. 2009; 9(3): 177–96.

Awtry EH, Philippides GJ. Alcoholic and cocaine-associated cardiomyopathies. Prog Cardiovasc Dis. 2010; 52(4): 289–99.

Bhargava S, Arora RR. Cocaine and cardiovascular complications. Am J Ther. 2011; 18(4): e95-e100.

Velasquez EM, Anand RC, Newman WP 3rd, Richard SS, Glancy DL. Cardiovascular complications associated with cocaine use. J La State Med Soc. 2004;156(6): 302–10.

Chokshi SK, Moore R, Pandian NG, Isner JM. Reversible cardiomyopathy associated with cocaine intoxication. Ann Intern Med. 1989; 111(12): 1039–40.

Virmani R, Robinowitz M, Smialek JE, Smyth DF. Cardiovascular effects of cocaine: an autopsy study of 40 patients. Am Heart J. 1988; 115(5): 1068–76.

Tazelaar HD, Karch SB, Stephens BG, Billingham ME. Cocaine and the heart. Hum Pathol. 1987; 18(2): 195–9.

Robledo-Carmona J, Ortega-Jimenez MV, Garcia-Pinilla JM, Cabra B, de Teresa E. Severe cardiomyopathy associated to cocaine abuse. Int J Cardiol. 2006; 112(1): 130-1.

Rangel C, Shu RG, Lazar LD, Vittinghoff E, Hsue PY, Marcus GM. Beta-blockers for chest pain associated with recent cocaine use. Arch Intern Med. 2010; 170(10): 874–9.

Littmann L, Narveson SY, Fesel MN, Marconi SL. Beta blocker treatment of heart failure patients with ongoing cocaine use. Int J Cardiol. 2013; 168 (3): 2919–20.

Smedema JP. Cardiac magnetic resonance predicts reversibility of cocaine-induced ventricular dysfunction. Cardiovasc J Afr. 2009; 20(3): 198–9.

McMurray JJ, Adamopoulos S, Anker SD, et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2012; 33(14): 1787–847.

DOI: http://dx.doi.org/10.24125/sanamed.v11i3.166

Refbacks

There are currently no refbacks.

This work is licensed under a Creative Commons Attribution 4.0 International License.

SANAMED